Emoritcha, Jasmir S.

HRN: 09-02-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/10/2023
12/16/2023
IV
500mg
Q8
Amoebiasis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: